First-Line Treatment of Hormone-Sensitive Metastatic Prostate Cancer: Is There a Single Standard of Care?
J Clin Oncol
.
2018 Apr 10;36(11):1060-1061.
doi: 10.1200/JCO.2017.77.4315.
Epub 2018 Feb 12.
Authors
Che-Kai Tsao
1
,
William K Oh
1
Affiliation
1
Che-Kai Tsao and William K. Oh, Icahn School of Medicine at Mount Sinai, New York, NY.
PMID:
29432079
DOI:
10.1200/JCO.2017.77.4315
No abstract available
Publication types
Editorial
Comment
MeSH terms
Androgen Antagonists
Humans
Male
Prostatic Neoplasms*
Standard of Care*
Survival Analysis
Substances
Androgen Antagonists